We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Industry

Image: The Miro Canvas system is a revolutionary digital microfluidics platform that automates NGS library prep. (Photo courtesy of Miroculus)

Integra Biosciences Acquires Biotechnology Specialist Miroculus to Advance Genomics Discoveries

INTEGRA Biosciences has acquired Miroculus, a biotech company focused on developing automation solutions that streamline NGS protocols. The acquisition will allow INTEGRA to extend its reach in the growing NGS market, providing novel process automation solutions to assist academic, research and diagnostics laboratories in saving time and speeding up discovery in this dynamic field. More...
20 Mar 2023
Image: Enzo’s GoTestMeNow online platform allows individuals to request and pay for routine lab tests online (Photo courtesy of Enzo Clinical Labs)

Enzo Biochem Sells Clinical Laboratory Division to Labcorp

Enzo Biochem has entered into an agreement for LabCorp Diagnostics to acquire the assets of Enzo’s Clinical Laboratory division. The deal between the two top global life sciences companies comes after several measures taken by Enzo in 2022 to further drive the company’s “focused return” initiative for maximizing shareholder value. More...
20 Mar 2023
Image: Werfen had reached an agreement in November 2022 to acquire Immucor for USD 2 billion (Photo courtesy of Werfen)

Werfen Completes Immucor Acquisition to Expand Leadership in Specialized Diagnostics

Werfen has successfully completed the acquisition of Immucor, a privately held in vitro diagnostics (IVD) company with a strong presence in the global Transfusion and Transplant markets, after receiving the required regulatory and antitrust approvals. More...
16 Mar 2023
Image: PerkinElmer has completed the divestiture of its applied, food and enterprise services businesses (Photo courtesy of PerkinElmer)

PerkinElmer Transforms into New Life Sciences & Diagnostics Company with Completion of Business Divestitures

PerkinElmer, Inc. (Waltham, MA; USA) has successfully completed the previously announced divestiture of its Applied, Food and Enterprise Services businesses. The resulting new, high-growth Life Sciences and Diagnostics business, focused on developing and delivering novel scientific breakthroughs that is expected to have a significant impact on improving global health, will share the PerkinElmer name with the Applied, Food and Enterprise Services businesses until a new name, brand and ticker symbol is introduced in Q2 2023 pending shareholder approval. More...
15 Mar 2023
Image: Sysmex and Siemens have established global agreement to supply hemostasis instruments and reagents as OEMs (Photo courtesy of Sysmex)

Siemens and Sysmex Sign Global Hemostasis Supply Agreement

Sysmex Corporation and Siemens Healthcare Diagnostics Inc. (Siemens Healthineers) have signed a global OEM agreement on hemostasis products under which each company will supply the other with their products in the diagnostic field of hemostasis on an OEM basis. More...
10 Mar 2023
Image: In the US, C13220-01MD NanoZoomer S360MD Slide scanner system is intended for in vitro diagnostic use (Photo courtesy of Hamamatsu)

Siemens Partners with Hamamatsu to Expand Into Digital Pathology in Americas and Europe

Siemens Healthineers has entered into a multi-year distribution agreement with Hamamatsu under which Hamamatsu will provide NanoZoomer whole slide scanners to support Siemens’ expansion into digital pathology in the Americas and Europe. More...
09 Mar 2023
Image: The global urinalysis market is expected to reach USD 6.5 billion in 2030 (Photo courtesy of Pexels)

Global Urinalysis Market Driven by Growing Demand for Point-of-Care Diagnostic Testing

The global urinalysis market is projected to grow at a CAGR of 6.7% from USD 1.87 billion in 2021 to USD 2.87 billion by 2030, driven by the rising incidence of kidney and urinary tract disorders, growing demand for point-of-care diagnostic testing, increase in aging population and higher healthcare expenditure. More...
01 Mar 2023
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2024 Globetech Media. All rights reserved.